BR0302496A - Composições farmacêuticas com atividade antibiótica - Google Patents

Composições farmacêuticas com atividade antibiótica

Info

Publication number
BR0302496A
BR0302496A BR0302496-2A BR0302496A BR0302496A BR 0302496 A BR0302496 A BR 0302496A BR 0302496 A BR0302496 A BR 0302496A BR 0302496 A BR0302496 A BR 0302496A
Authority
BR
Brazil
Prior art keywords
pharmaceutical compositions
antibiotic activity
antibiotic
activity
stabilizers
Prior art date
Application number
BR0302496-2A
Other languages
English (en)
Other versions
BRPI0302496B8 (pt
BRPI0302496B1 (pt
BRPI0302496C1 (pt
Inventor
Luca Rampoldi
Luca Pirrone
Sarah Faccin
Alessandro Grassano
Giavanni Gurrieri
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27638551&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0302496(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Zambon Spa filed Critical Zambon Spa
Publication of BR0302496A publication Critical patent/BR0302496A/pt
Publication of BRPI0302496B1 publication Critical patent/BRPI0302496B1/pt
Publication of BRPI0302496B8 publication Critical patent/BRPI0302496B8/pt
Publication of BRPI0302496C1 publication Critical patent/BRPI0302496C1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/336—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)

Abstract

"COMPOSIçõES FARMACêUTICAS COM ATIVIDADE ANTIBIóTICA". Descreve-se o uso de certos sais e aminoácidos como estabilizadores do antibiótico Fosfomicina Trometamol e composições farmacêuticas que os contêm.
BRPI0302496A 2002-08-01 2003-07-29 composições farmacêuticas com atividade antibiótica BRPI0302496C1 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT001725A ITMI20021725A1 (it) 2002-08-01 2002-08-01 Composizioni farmaceutiche ad attivita' antibiotica.

Publications (4)

Publication Number Publication Date
BR0302496A true BR0302496A (pt) 2004-08-24
BRPI0302496B1 BRPI0302496B1 (pt) 2015-07-28
BRPI0302496B8 BRPI0302496B8 (pt) 2016-09-13
BRPI0302496C1 BRPI0302496C1 (pt) 2021-05-25

Family

ID=27638551

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0302496A BRPI0302496C1 (pt) 2002-08-01 2003-07-29 composições farmacêuticas com atividade antibiótica

Country Status (29)

Country Link
US (1) US7303755B2 (pt)
JP (1) JP4395338B2 (pt)
KR (1) KR100966977B1 (pt)
AT (1) AT500521B1 (pt)
BE (1) BE1017903A3 (pt)
BR (1) BRPI0302496C1 (pt)
CA (1) CA2434927C (pt)
CH (1) CH696718A5 (pt)
CO (1) CO5480297A1 (pt)
CZ (1) CZ305023B6 (pt)
DE (1) DE10334820B4 (pt)
DK (1) DK178348B1 (pt)
ES (1) ES2224869B1 (pt)
FI (1) FI120080B (pt)
FR (1) FR2852845B1 (pt)
GR (1) GR20030100300A (pt)
HR (1) HRP20030618B1 (pt)
HU (1) HU230575B1 (pt)
IL (1) IL156615A (pt)
IT (1) ITMI20021725A1 (pt)
NL (1) NL1023790C2 (pt)
PL (1) PL209644B1 (pt)
PT (1) PT102995B (pt)
RU (1) RU2333000C2 (pt)
SE (1) SE527466C2 (pt)
SI (1) SI21259B (pt)
SK (1) SK287201B6 (pt)
TR (1) TR200301248A2 (pt)
ZA (1) ZA200305040B (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE740685C (de) * 1941-04-11 1943-10-26 Voigt & Haeffner Ag Viertakt-Regelschalter fuer Parallel-, Einzel- und Reihenschaltung von Heizwiderstaenden
ES2244333B1 (es) * 2004-05-18 2006-08-01 Simbec Iberica, Sl Preparado farmaceutico oral de fosfomicina estable y apto para diabeticos.
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
EP4209210A1 (en) 2009-10-02 2023-07-12 Boehringer Ingelheim International GmbH Pharmaceutical compositions comprising bi-1356 and metformin
EA021876B1 (ru) * 2010-09-20 2015-09-30 ЛИМОНОВ, Виктор Львович Фармацевтическая композиция антимикробного и противовоспалительного действия для парентерального введения, способ ее получения
ES2385158B1 (es) 2010-12-24 2013-05-28 Arafarma Group, S.A. Composición farmacéutica de fosfomicina
CN102579466A (zh) * 2011-01-10 2012-07-18 王乐 一种磷霉素或磷霉素精氨酸盐与精氨酸的组合物
US8604078B2 (en) * 2011-04-06 2013-12-10 Carlos Picornell Darder Fosfomycin pharmaceutical composition
US20140323443A1 (en) * 2013-04-30 2014-10-30 Fresenius Kabi Usa, Llc Tigecycline formulations
ITTO20130839A1 (it) * 2013-10-16 2015-04-17 C & G Farmaceutici S R L Composizione a base di fosfomicina trometamolo
DE102014218913A1 (de) * 2014-09-19 2016-03-24 Heraeus Medical Gmbh Verfahren zur Herstellung eines antibiotischen Polymehtylmethacrylat-Knochenzementpulvers und ein antibiotisches Polymethtylmethacrylat-Knochenzementpulver
CN104546689B (zh) * 2015-01-07 2019-01-25 同方药业集团有限公司 一种含有甲硝唑的药物组合物
WO2017111718A1 (en) 2015-12-25 2017-06-29 Yusuf Toktamiş Öğün The formulation comprising phosphomycine and ascorbic acid for the treatment of bacterial urinary system infections
CA3147662A1 (en) 2021-02-10 2022-08-10 Labiana Health, S.L. New fosfomycin tablet formulations

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3852434A (en) * 1970-09-11 1974-12-03 Merck & Co Inc Potentiation of ({31 ) cis-1,2-epoxypropyl)phosphonic acid and analogues thereof
IT1161974B (it) 1978-02-02 1987-03-18 Italchemi Spa Derivti dell acido cis.i 2 epossipropilfosfonico loro procedimento di preparazione e composizioni farmaceutiche che li contengono
IT1112282B (it) * 1978-07-19 1986-01-13 Zambon Spa Bis-(2-ammonio-2-idrossimetil-1,3-propandiolo)(2r-cis)-(3-metilossiranil)fosfonato
IT1124610B (it) * 1979-10-18 1986-05-07 Zambo Spa Mono(2-ammonio-2-idrossimetil-1,3-propandiolo) (2r-cis)-(o-metilossiranil)fosfonato
JPS59104326A (ja) * 1982-12-04 1984-06-16 Toyo Jozo Co Ltd マクロライド抗生物質の安定な経口用製剤および安定化法
CH660305A5 (de) * 1984-10-05 1987-04-15 Schering Spa Wasserloesliche pharmazeutische zusammensetzungen auf der basis von salzen der (-)cis-1,2-epoxypropylphosphonsaeure mit aminosaeuren.
EP0390930B1 (en) * 1988-09-26 1993-03-03 Teijin Limited Stable aqueous preparation of active vitamin d 3
US5191094A (en) * 1989-07-27 1993-03-02 Zambon Group S.P.A. Mono (2-ammonium-2-hydroxymethyl-1,3-propanediol) (2R,cis)-1,2-epoxypropyl-phosphonate with improved characteristics of stability and processing
IT1231013B (it) * 1989-07-27 1991-11-08 Zambon Spa Mono (2 ammonio 2 idrossimetil 1,3 propandiolo)(2r,cis) 1,2 epossipropil fosfonato avente migliorate caratteristiche di stabilita' e lavorabilita'.
IT1244543B (it) 1991-02-01 1994-07-15 La Fa Re Srl Uso topico della fosfomicina e dei suoi sali nella terapia delle infezioni vaginali e/o uretrali
FR2690340B1 (fr) 1992-04-24 1995-02-24 Scr Newmed Nouveau procédé de stabilisation des préparations pharmaceutiques liquides et les compositions pharmaceutiques ainsi stabilisées en résultant.
CA2091152C (en) 1993-03-05 2005-05-03 Kirsten Westesen Solid lipid particles, particles of bioactive agents and methods for the manfuacture and use thereof
DE4327063A1 (de) * 1993-08-12 1995-02-16 Kirsten Dr Westesen Ubidecarenon-Partikel mit modifizierten physikochemischen Eigenschaften
CA2153553A1 (en) * 1994-07-13 1996-01-14 Hidekazu Suzuki Stable lipid emulsion
JPH09183730A (ja) * 1995-05-10 1997-07-15 Meiji Seika Kaisha Ltd ホスホマイシン鏡像異性体を含んでなる医薬
DE19712565A1 (de) 1997-03-25 1998-10-01 Thomas W Dr Stief Arzneimittel auf der Basis eines Singulett-Sauerstoff erzeugenden Agenzes
WO2001097851A2 (en) * 2000-06-21 2001-12-27 Cubist Pharmaceuticals, Inc. Compositions and methods to improve the oral absorption of antimicrobial agents
WO2002032459A2 (en) * 2000-10-17 2002-04-25 Massachusetts Institute Of Technology Method of increasing the efficacy of antibiotics by complexing with cyclodextrins
US7378408B2 (en) 2001-11-30 2008-05-27 Pfizer Inc. Methods of treatment and formulations of cephalosporin
TW200403240A (en) * 2002-06-28 2004-03-01 Upjohn Co Difluorothioacetamides of oxazolidinones as antibacterial agents

Also Published As

Publication number Publication date
SE527466C2 (sv) 2006-03-14
CA2434927A1 (en) 2004-02-01
PL209644B1 (pl) 2011-09-30
HRP20030618B1 (en) 2011-10-31
RU2333000C2 (ru) 2008-09-10
ITMI20021725A1 (it) 2002-10-31
ES2224869A1 (es) 2005-03-01
FI120080B (fi) 2009-06-30
FR2852845A1 (fr) 2004-10-01
IL156615A0 (en) 2004-01-04
PT102995A (pt) 2004-02-27
JP4395338B2 (ja) 2010-01-06
ES2224869B1 (es) 2007-07-01
SE0302129L (sv) 2004-02-02
FI20031078A0 (fi) 2003-07-16
SE0302129D0 (sv) 2003-07-25
KR100966977B1 (ko) 2010-06-30
HU230575B1 (hu) 2017-02-28
DE10334820B4 (de) 2020-02-06
SI21259B (sl) 2012-12-31
US20040022866A1 (en) 2004-02-05
BE1017903A3 (fr) 2009-11-03
BRPI0302496B8 (pt) 2016-09-13
AT500521A1 (de) 2006-01-15
BRPI0302496B1 (pt) 2015-07-28
CH696718A5 (it) 2007-10-31
FI20031078A (fi) 2004-02-02
CZ305023B6 (cs) 2015-04-01
HU0302441D0 (en) 2003-09-29
BRPI0302496C1 (pt) 2021-05-25
HRP20030618A2 (en) 2004-04-30
FR2852845B1 (fr) 2006-01-06
SI21259A (sl) 2004-02-29
HUP0302441A2 (hu) 2005-07-28
AT500521B1 (de) 2007-11-15
KR20040012569A (ko) 2004-02-11
NL1023790A1 (nl) 2004-02-03
CO5480297A1 (es) 2005-01-28
TR200301248A2 (tr) 2004-02-23
CA2434927C (en) 2011-10-18
SK287201B6 (sk) 2010-03-08
IL156615A (en) 2008-11-26
DK200301097A (da) 2004-02-02
NL1023790C2 (nl) 2004-03-10
PT102995B (pt) 2004-07-30
CZ20032096A3 (cs) 2004-03-17
US7303755B2 (en) 2007-12-04
RU2003124299A (ru) 2005-01-20
SK9762003A3 (en) 2004-02-03
PL361518A1 (en) 2004-02-09
JP2004067682A (ja) 2004-03-04
GR20030100300A (el) 2004-04-22
DE10334820A1 (de) 2004-03-11
ZA200305040B (en) 2004-05-11
DK178348B1 (da) 2016-01-04

Similar Documents

Publication Publication Date Title
BRPI0302496B8 (pt) composições farmacêuticas com atividade antibiótica
BRPI0519148A2 (pt) inibidores de homodimerizaÇço de myd88
ATE469136T1 (de) Inhibitoren von 11-beta- hydroxysteroiddehydrogenase typ 1
BR0111222A (pt) Derivados fosfonados de glicopeptìdeo
BR0116032A (pt) imidazoquinolinas substituìdas com sulfonamido éster
BR0014214A (pt) Imidazoquinolinas substituìdas com amida
BR9916894A (pt) ácidos sulfohidroxâmicos e sulfohidroxamatos eseu uso como inibidores de mek
ECSP088503A (es) COMPUESTOS de LACTAMa y MÉTODOS DE USO DE LOS MISMOS
BR0308339A (pt) Indazóis substituìdos com uma atividade anticancerosa
BR0314393A (pt) Piperazinas heterocìclicas substituìdas para o tratamento de esquizofrenia
BR0015605A (pt) Composição e uso
BR0211623A (pt) Agentes de contraste alvos multiméricos com base em peptìdeo
BRPI0514372A (pt) inibidores de tiazol de frutose 1, 6-bisfosfatase
DK1413582T3 (da) Dimere pyrrolobenzodiazepiner
SV2001000004A (es) Difenil ureas w-carboxyaril sustituidas, composición farmacéutica que las comprende y su uso como inhibidores de raf quinasa
MX9206008A (es) Inhibidores de enzima proteolitica, derivados de sacarina 2-substituida.
RS50510B (sr) Formulacije koje sadrže ekteinascidin i disaharid
RS51694B (en) NEW PERINDOPRIL AND PHARMACEUTICAL COMPOSITIONS CONTAINING THERE
BRPI0519479A2 (pt) anÁlogos de benzazol 2,5 e 2,6-dissubstituÍdo éteis como inibidores de proteÍna quinase, composiÇço e uso dos mesmos
BRPI0408240A (pt) composto, utilização de um composto e composição farmacêutica
BRPI0410861A (pt) métodos e composições para a produção de aminoácidos
BR0308765A (pt) Compostos (4,2-dissubstituìdo-tiazol-5-il)amina como inibidores de pde7
BR0314195A (pt) Derivados de piridina substituìda como agentes antitumorais
BR0314352A (pt) Indóis 2,7-substituìdos e seu uso como moduladores de 5-ht6
UY25211A1 (es) Inhibidores de isoquinolinilguanidina uroquinasa

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 28/07/2015, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: REFERENTE A PUBLICACAO DO DESPACHO 16.1 PUBLICADO NA RPI 2325 DE 28.07.2015, QUANTO AO NOME DO INVENTOR

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 29/07/2003 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF